Clinical trial
The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a…
NCT00375388 · Bethesda General Hospital, Hoogeveen, Other · Completed
Key facts
| NCT number | NCT00375388 |
|---|---|
| Title | The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial |
| Official title | Study of Metformin HCL in Patients With Type 2 Diabetes Intensively Treated With Insulin: a Treatment Strategy for Insulin Resistance in Type 2 Diabetes Mellitus: a Randomized Controlled Trial |
| Lead sponsor | Bethesda General Hospital, Hoogeveen, Other |
| Collaborators | Takeda Industry LifeScan Merck KGaA, Darmstadt, Germany Dupont Merck Merck Sharp & Dohme LLC Novo Nordisk A/S |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Metformin on top of intensive insulin therapy |
| Enrollment | 400 |
| Start date | Jan 1, 1998 |
| Completion | Oct 1, 2002 |
| First posted | Sep 13, 2006 |
| Last update posted | Sep 13, 2006 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: